JAKARTA - The Ministry of Health (Kemenkes) reported that a patient with suspected failure status of an Atypical Progresive Acute Kidney (GGAPA) in Jakarta experienced specific symptoms of noquities or difficulty urinating before being hit by fever and death.

"The symptoms are difficult (to throw urine). Starting before fever, cough, runny nose," said Head of the Public Communication and Service Bureau of the Ministry of Health, Siti Nadia Tarmizi, quoted by ANTARA, Monday, February 6.

He said the symptoms of difficulty urinating known as medical as Anuria got worse after patients took cirrhop drugs containing parasentamol. However, the brand of the drug was not mentioned.

The chronology of suspected patients was experienced by a 7-year-old child. He had a fever on January 26, 2023, then took a hot reduction drug that was bought independently.

For four days later, the patient received a reduction in tablet fever treatment from the puskesmas. On February 1, 2023, patients seek treatment at the clinic and are given concoction drugs.

The next day the patient was treated at the Kembangan Hospital and then referred and is currently undergoing intensive treatment at the Jakarta RSCM.

Nadia appealed to the public not to buy their own medicine in pharmacies first during the investigation process of the incident.

The process of investigating the case was carried out to reveal the connection between the incident that befell the patient and the alleged contamination of the chemical compound Ethen Glikol/Diethilen Glikol (EG/DEG) which exceeded the safe limit.

The safe boundary threshold for EG/DEG contamination in the solvent raw materials for the Glikol Propilent drug circle is set at less than 0.1 percent, while the safe threshold or Tolerable Daily Intake (TDI) for EG and DEG contamination in drugANGles does not exceed 0.5 mg/kg of body weight per day.

If the raw material exceeds the provisions of a safe threshold, it risks triggering kidney damage to the point of death.

According to him, an investigation is needed to anticipate the addition of GGAPA cases due to drug poisoning that occurred in Indonesia.

Previously reported, two DKI Jakarta residents aged 1 and 7 were reported to have experienced GGAPA. One confirmed case died and the other was a suspect and was undergoing intensive treatment.

With the addition of new cases of GGAPA reported, as of February 5, 2023, there were 326 GGAPA cases and one suspected spread across 27 provinces in Indonesia.

Of these, 116 cases were declared cured, while six cases were still undergoing treatment at the Jakarta RSCM.


The English, Chinese, Japanese, Arabic, and French versions are automatically generated by the AI. So there may still be inaccuracies in translating, please always see Indonesian as our main language. (system supported by DigitalSiber.id)